The expanding family of regulatory B cells
Claudia Mauri and
Madhvi Menon
+
Centre for Rheumatology, Division of Medicine, University College London, 5 University Street, London WC1E 6JF, UK
- Correspondence to: C. Mauri; E-mail: c.mauri@ucl.ac.uk
Abstract Over the last decade it has become evident that in addition to producing antibody, B cells activate the immune system by producing cytokines and via antigen presentation. In addition, B cells also exhibit immunosuppressive functions via diverse regulatory mechanisms. This subset of B cells, known as regulatory B cells (Bregs), contributes to the maintenance of tolerance, primarily via the production of IL-10. Studies in experimental animal models, as well as in patients with autoimmune diseases, have identified multiple Breg subsets exhibiting diverse mechanisms of immune suppression. In this review, we describe the different Breg subsets identified in mice and humans, and their diverse mechanisms of suppression in different disease settings.
This ArticleInt. Immunol. (2015)doi: 10.1093/intimm/dxv038First published online: June 12, 2015
- This article is Open Access
Full Text (HTML)Free
Full Text (PDF)Free
No comments:
Post a Comment